We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

VITL:NASDAQVital Farms, Inc. Analysis

Data as of 2026-07-29 - not real-time

$13.68

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Vital Farms trades around $13.70, comfortably above its 20‑day SMA of ~13.10 but still below the 50‑day SMA of ~11.4, while the 200‑day SMA sits near $21.7, signaling a long‑term downtrend. Momentum indicators are mixed: RSI is in the low 60s, suggesting the stock is approaching overbought levels, and the MACD histogram has turned negative, giving a bearish signal. Volatility is elevated at roughly 53% over the past month and beta hovers near 1.0, indicating market‑aligned price swings. Fundamentally, revenue is growing at about 15% year‑over‑year, yet operating margins are negative and free cash flow is deeply in the red, while debt remains modest relative to equity. A discounted cash‑flow model values the company near $3.90, implying a downside of more than 12% from current levels, and analysts’ consensus remains a “buy” despite these red flags. Recent news shows a short‑term price rally of nearly 6% on sector‑wide optimism after General Mills’ strong results, followed by a pullback to the low $12s, underscoring the stock’s sensitivity to broader consumer‑staples sentiment.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish MACD histogram and proximity to resistance around $14.05
  • High short‑term volatility and recent price swing from $12.78 to $13.68
  • Positive earnings per share but negative free cash flow

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Revenue growth of ~15% offset by negative operating margins
  • DCF fair value far below market price, indicating overvaluation
  • Stable volume and modest debt but continued cash‑flow deficits

Long Term

> 3 years
Cautious
Model confidence: 4/10

Key Factors

  • Significant valuation gap (market price vs. $3.90 DCF estimate)
  • Persistent free‑cash‑flow negativity and margin compression
  • Elevated volatility and market‑aligned beta suggesting limited downside protection

Key Metrics & Analysis

Financial Health

Revenue Growth15.40%
Profit Margin6.10%
P/E Ratio13.2
ROE15.44%
ROA9.24%
Debt/Equity16.39
P/B Ratio1.7
Op. Cash Flow$9.9M
Free Cash Flow$-53856752

Technical Analysis

TrendNeutral
RSI61.7
Support$11.49
Resistance$14.06
MA 20$13.10
MA 50$11.41
MA 200$21.75
MACDBearish
VolumeStable
Fear & Greed Index84.54

Valuation

Fair Value$3.89
Target Price$12.00
Upside/Downside-12.28%
GradeOvervalued
TypeBlend

Risk Assessment

Beta0.01
Volatility52.83%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.